Professor | Weiting Cheng | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Weiting Cheng
Contact Information	chengweiting@whu.edu.cn
Language ability	English, Chinese
Province	Hubei

Upload Avatar (500 x 500)

Name

Weiting Cheng

Contact Information

chengweiting@whu.edu.cn

Language ability

English, Chinese

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Medical School
Academic Background & Achievements	1999-2004: Bachelor's Degree from Tongji Medical College, Huazhong University of Science and Technology 2004-2009: PhD from Tongji Medical College, Huazhong University of Science and Technology Currently holds grants from Hubei Provincial Natural Science Foundation and Wuhan Municipal Health Commission Published over 20 papers, including more than 10 SCI papers
Work Experience	2009-2015: Attending Physician, Oncology, Tongji Medical College, Huazhong University of Science and Technology 2015-2016: Postdoctoral Research, Oncology Drug Research Center, University of Munich, Germany 2016-2023: Associate Chief Physician, Master Tutor, Oncology, Tongji Medical College, Huazhong University of Science and Technology 2023-Present: Associate Chief Physician, Master Tutor, Oncology, Renmin Hospital, Wuhan University
Awards	2019: Top 50 of the National Youth Doctor All-Star Plan by the Ministry of Health 2011: Wuhan Science and Technology Achievement Award for the study on the protective effects of 'Lung Fiber Formula' against radiation pneumonia

University/Lab Affiliation and Title

Wuhan University

Faculty

Medical School

Academic Background & Achievements

1999-2004: Bachelor's Degree from Tongji Medical College, Huazhong University of Science and Technology
2004-2009: PhD from Tongji Medical College, Huazhong University of Science and Technology
Currently holds grants from Hubei Provincial Natural Science Foundation and Wuhan Municipal Health Commission
Published over 20 papers, including more than 10 SCI papers

Work Experience

2009-2015: Attending Physician, Oncology, Tongji Medical College, Huazhong University of Science and Technology
2015-2016: Postdoctoral Research, Oncology Drug Research Center, University of Munich, Germany
2016-2023: Associate Chief Physician, Master Tutor, Oncology, Tongji Medical College, Huazhong University of Science and Technology
2023-Present: Associate Chief Physician, Master Tutor, Oncology, Renmin Hospital, Wuhan University

Awards

2019: Top 50 of the National Youth Doctor All-Star Plan by the Ministry of Health
2011: Wuhan Science and Technology Achievement Award for the study on the protective effects of 'Lung Fiber Formula' against radiation pneumonia

Areas of Focus	Impact of active ingredients in traditional Chinese medicine on tumor cell energy metabolism Regulatory role of autophagy in the progression of malignant tumors
Publications	Casereport: Mycobacterium neoaurum infection during ICI therapy in a hepatocellular carcinoma patient with psoriasis, Pang L, Chen JZ, Xu D, Cheng WT, 2022 Differential early diagnosis of benign versus malignant lung cancer using systematic pathway flux analysis of peripheral blood leukocytes, Li X, Li M, Qiu H, Saad C, Zhao B, Li F, Wu X, Kuang D, Tang F, Chen Y, Shu H, Zhang J, Wang Q, Huang H, Qi S, Ye C, Bryant A, Yuan X, Kurts C, Hu G, Cheng W, Mei Q, 2022 Comprehensive Analysis of Key mRNAs and lncRNAs in Osteosarcoma Response to Preoperative Chemotherapy with Prognostic Values, Li M, Cheng WT, Li H, Zhang Z, Lu XL, Deng SS, Li J, Yang CH, 2021 Complement C3 identified as an unique risk factor for disease severity among young COVID-19 patients in Wuhan, China, Cheng WT, Hornung R, Xu K, Yang CH, Li J, 2021 Analysis of clinical features of COVID-19 in cancer patients, Cheng WT, Ke YH, Yang GY, Sun H, Chen Y, Ying RY, Zeng XH, Shen D, Tang KJ, Xu K, Yu F, 2020 Tanshinone IIA ameliorates oxaliplatin-induced neurotoxicity via mitochondrial protection and autophagy promotion, Cheng WT, Xiang W, Wang S, Kai Xu, 2019 Role of Hedgehog signaling pathway in proliferation and invasion of hepatocellular carcinoma, Cheng WT, Xu K, Tian DY, Zhang ZD, Liu LJ, Chen Y, 2009 Neocarzilin A Is a Potent Inhibitor of Cancer Cell Motility Targeting VAT-1 Controlled Pathways, Gleissner CM, Pyka CL, Heydenreuter W, Gronauer TF, Atzberger C, Cheng WT, Hacker SM, Vollmar AM, Braig S, Sieberet SA, 2019 HDAC6 inhibition suppresses chondrosarcoma by restoring the expression of primary cilia, Xiang W, Guo F, Cheng WT, Zhang J, Huang J, Wang R, Ma Z, Xu K, 2017 Evaluating the role of PTH in promotion of chondrosarcoma cell proliferation and invasion by inhibiting primary cilia expression, Xiang W, Jiang T, Guo F, Xu T, Gong C, Cheng P, Zhao L, Cheng WT, Xu K, 2014 Hedgehog pathway inhibitor-4 suppresses malignant properties of chondrosarcoma cells by disturbing tumor ciliogenesis, Xiang W, Jiang T, Guo F, Gong C, Yang K, Wu Y, Huang X, Cheng WT, Xu K, 2014

Areas of Focus

Impact of active ingredients in traditional Chinese medicine on tumor cell energy metabolism
Regulatory role of autophagy in the progression of malignant tumors

Publications

Casereport: Mycobacterium neoaurum infection during ICI therapy in a hepatocellular carcinoma patient with psoriasis, Pang L, Chen JZ, Xu D, Cheng WT, 2022
Differential early diagnosis of benign versus malignant lung cancer using systematic pathway flux analysis of peripheral blood leukocytes, Li X, Li M, Qiu H, Saad C, Zhao B, Li F, Wu X, Kuang D, Tang F, Chen Y, Shu H, Zhang J, Wang Q, Huang H, Qi S, Ye C, Bryant A, Yuan X, Kurts C, Hu G, Cheng W, Mei Q, 2022
Comprehensive Analysis of Key mRNAs and lncRNAs in Osteosarcoma Response to Preoperative Chemotherapy with Prognostic Values, Li M, Cheng WT, Li H, Zhang Z, Lu XL, Deng SS, Li J, Yang CH, 2021
Complement C3 identified as an unique risk factor for disease severity among young COVID-19 patients in Wuhan, China, Cheng WT, Hornung R, Xu K, Yang CH, Li J, 2021
Analysis of clinical features of COVID-19 in cancer patients, Cheng WT, Ke YH, Yang GY, Sun H, Chen Y, Ying RY, Zeng XH, Shen D, Tang KJ, Xu K, Yu F, 2020
Tanshinone IIA ameliorates oxaliplatin-induced neurotoxicity via mitochondrial protection and autophagy promotion, Cheng WT, Xiang W, Wang S, Kai Xu, 2019
Role of Hedgehog signaling pathway in proliferation and invasion of hepatocellular carcinoma, Cheng WT, Xu K, Tian DY, Zhang ZD, Liu LJ, Chen Y, 2009
Neocarzilin A Is a Potent Inhibitor of Cancer Cell Motility Targeting VAT-1 Controlled Pathways, Gleissner CM, Pyka CL, Heydenreuter W, Gronauer TF, Atzberger C, Cheng WT, Hacker SM, Vollmar AM, Braig S, Sieberet SA, 2019
HDAC6 inhibition suppresses chondrosarcoma by restoring the expression of primary cilia, Xiang W, Guo F, Cheng WT, Zhang J, Huang J, Wang R, Ma Z, Xu K, 2017
Evaluating the role of PTH in promotion of chondrosarcoma cell proliferation and invasion by inhibiting primary cilia expression, Xiang W, Jiang T, Guo F, Xu T, Gong C, Cheng P, Zhao L, Cheng WT, Xu K, 2014
Hedgehog pathway inhibitor-4 suppresses malignant properties of chondrosarcoma cells by disturbing tumor ciliogenesis, Xiang W, Jiang T, Guo F, Gong C, Yang K, Wu Y, Huang X, Cheng WT, Xu K, 2014

Traditional Chinese Medicine Tumor Cell Energy Metabolism Active Ingredients Autophagy Malignant Tumors Regulation Disease Progression Cellular Mechanisms Therapeutic Targets

Benhong Zhou - Wuhan University

Honglei Chen - Wuhan University

Xin Yi - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us